Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as effect on dendritic cell population in CNS by measuring change in CD11c level at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as effect on dendritic cell population in draining lymph nodes by measuring change in CD11c level at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as effect on dendritic cell population in spleen by measuring change in CD11c level at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis
Inhibition of M1 polarization in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as CD86 level in CNS at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis (Rvb = 26.3%)
Inhibition of M1 polarization in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as CD86 level in draining lymph nodes at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis (Rvb = 18.4%)
Inhibition of M1 polarization in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as CD86 level in spleen at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis (Rvb = 11.8%)
Induction of M2 polarization in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as CD206 level in CNS at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis (Rvb = 7.8%)
Induction of M2 polarization in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as CD206 level in draining lymph nodes at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis (Rvb = 6.5%)
Induction of M2 polarization in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as CD206 level in spleen at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 13 to 19 days post-immunization by flow cytometry analysis (Rvb = 23.4%)
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as TH17 cell population in spinal cord by measuring IL17 level at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 14 to 21 days post-immunization by flow cytometry analysis (Rvb = 7.7%)
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as TH1 cell population in spinal cord by measuring IFNgamma level at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 14 to 21 days post-immunization by flow cytometry analysis (Rvb = 22.3%)
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as reduction in demyelination in spinal cord at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 14 days post-immunization by H and E staining based microscopic analysis
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as reduction in infiltration in spinal cord at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 14 days post-immunization by H and E staining based microscopic analysis
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as reduction in demyelination in spinal cord at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 14 days post-immunization by LFB staining based microscopic analysis
Antiinflammatory activity in C57BL/6J mouse model of MOG (35 to 55 residues)/pertussis toxin/complete Freund's adjuvant-induced experimental allergic encephalomyelitis assessed as reduction in infiltration in spinal cord at 200 mg/kg, ig administered daily starting from 7 days post-immunization measured after 14 days post-immunization by LFB staining based microscopic analysis
Inhibition of LPS-induced M1 polarization in C57BL/6J mouse BMDM cells assessed as down regulation of CD86 expression at 300 nM measured after 24 hrs by FACS analysis
Modulation of M2 polarization in C57BL/6J mouse BMDM cells assessed as up regulation of CD206 expression at 300 nM measured after 24 hrs by FACS analysis
Modulation of M1 polarization in C57BL/6J mouse BMDM cells assessed as up regulation of TNFalpha expression at 300 nM measured after 4 to 24 hrs by Western blot analysis
Modulation of M2 polarization in C57BL/6J mouse BMDM cells assessed as up regulation of YM1 expression at 300 nM measured after 4 to 24 hrs by Western blot analysis